Search Results 3541-3550 of 22476 for oral

1. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

2. Publications - Michael C. Stephens, M.D. - Mayo Clinic

   The Role of Oral Administration of Immunoglobulin in Managing Diarrheal Illness in Immunocompromised Children. Paediatr Drugs. 2020 Jun; 22 (3):331-334. View ...

3. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

   Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is ...

4. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects who have initiated or had a dose change of any of the following within 2 weeks of screening: oral, topical, or intravenous (IV) vasodilators (e.g. ...

5. Baby teeth: When do children start losing them? - Mayo Clinic

   When children lose baby teeth, it's a good time to talk about how to care for the mouth, called oral healthcare. For instance: Remind children to brush ...

6. Hematology - Clinical trials

   ... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...

7. Chrisandra L. Shufelt, M.D. - Mayo Clinic Faculty Profiles

   Shufelt's expertise focuses on the role of endogenous reproductive hormones, oral contraceptives and menopause hormone therapy in cardiovascular risk factors ...

8. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Participation eligibility · combined hormonal (oestrogen and progestogen containing) contraception, which may be oral, intravaginal, or transdermal; · progestogen ...

9. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

   ... oral antibiotics within 2 weeks prior to screening visit;; Participation in another therapeutic trial within 30 days of enrollment or 5 half-lives of the ...

10. Visiting Medical Student Clerkships - Laboratory Medicine and Pathology, Anatomic Pathology (Minnesota)

    As part of this program, you prepare an oral presentation on an interesting case, generally a case seen in surgical pathology or autopsy service. However if ...